DK0598899T3 - Væskefasesyntese af peptider og peptidderivater - Google Patents

Væskefasesyntese af peptider og peptidderivater

Info

Publication number
DK0598899T3
DK0598899T3 DK93916581T DK93916581T DK0598899T3 DK 0598899 T3 DK0598899 T3 DK 0598899T3 DK 93916581 T DK93916581 T DK 93916581T DK 93916581 T DK93916581 T DK 93916581T DK 0598899 T3 DK0598899 T3 DK 0598899T3
Authority
DK
Denmark
Prior art keywords
peptides
liquid phase
peptide derivatives
phase synthesis
protecting group
Prior art date
Application number
DK93916581T
Other languages
English (en)
Inventor
Gary A Siwruck
John S Eynon
Original Assignee
Kinerton Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kinerton Ltd filed Critical Kinerton Ltd
Application granted granted Critical
Publication of DK0598899T3 publication Critical patent/DK0598899T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/064—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for omega-amino or -guanidino functions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK93916581T 1992-06-16 1993-06-16 Væskefasesyntese af peptider og peptidderivater DK0598899T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE194292A IE921942A1 (en) 1992-06-16 1992-06-16 Liquid phase synthesis of peptides and peptide derivatives
PCT/US1993/005783 WO1993025571A1 (en) 1992-06-16 1993-06-16 Liquid phase synthesis of peptides and peptide derivatives

Publications (1)

Publication Number Publication Date
DK0598899T3 true DK0598899T3 (da) 1999-02-08

Family

ID=11039683

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93916581T DK0598899T3 (da) 1992-06-16 1993-06-16 Væskefasesyntese af peptider og peptidderivater

Country Status (11)

Country Link
EP (1) EP0598899B1 (da)
JP (1) JPH06509821A (da)
AT (1) ATE171708T1 (da)
AU (1) AU671660B2 (da)
CA (1) CA2115668A1 (da)
DE (1) DE69321324T2 (da)
DK (1) DK0598899T3 (da)
ES (1) ES2123059T3 (da)
IE (1) IE921942A1 (da)
NZ (1) NZ254389A (da)
WO (1) WO1993025571A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE37160E1 (en) * 1990-06-12 2001-05-01 Rutgers, The State University Synthesis of tyrosine derived diphenol monomers
US5587507A (en) * 1995-03-31 1996-12-24 Rutgers, The State University Synthesis of tyrosine derived diphenol monomers
US5874532A (en) * 1997-01-08 1999-02-23 Nexstar Pharmaceuticals, Inc. Method for solution phase synthesis of oligonucleotides and peptides
ATE376556T1 (de) 2003-12-31 2007-11-15 Hoffmann La Roche Verfahren zur peptidsynthese unter verwendung einer reduzierten menge an entschützungsmittel
WO2005063799A2 (en) * 2003-12-31 2005-07-14 F.Hoffmann-La Roche Ag Peptide synthesis and deprotection with co-solvent
ES2729197T3 (es) 2006-03-01 2019-10-30 Kaneka Corp Método de producción de péptidos
JP5212371B2 (ja) * 2007-07-25 2013-06-19 味の素株式会社 ペプチドの製造方法
WO2014147129A1 (en) 2013-03-21 2014-09-25 Sanofi-Aventis Deutschland Gmbh Synthesis of cyclic imide containing peptide products
SG11201506804VA (en) 2013-03-21 2015-09-29 Sanofi Aventis Deutschland Synthesis of hydantoin containing peptide products
JP6713983B2 (ja) * 2015-03-04 2020-06-24 Jitsubo株式会社 ペプチド合成方法
WO2017112809A1 (en) 2015-12-21 2017-06-29 Taxas Tech University System System and method for solution phase gap peptide synthesis
WO2019231760A1 (en) * 2018-05-31 2019-12-05 Gap Peptides Llc Method for solution-phase peptide synthesis and protecting strategies therefore
US11827660B2 (en) 2019-02-01 2023-11-28 Sederma Synthesis strategy for gap protecting group

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121707A (en) * 1960-11-23 1964-02-18 American Cyanamid Co Peptide synthesis using n-n' carbonyldiimidazole activator
US3769271A (en) * 1971-04-15 1973-10-30 Lilly Co Eli N-protected amino acids and peptides
US4581168A (en) * 1983-02-21 1986-04-08 Sanofi Synthesis of hpGRF (Somatocrinin) in liquid phase and intermediate peptides
US4859736A (en) * 1987-03-30 1989-08-22 Ciba-Geigy Corporation Synthetic polystyrene resin and its use in solid phase peptide synthesis

Also Published As

Publication number Publication date
EP0598899A4 (en) 1995-08-16
ATE171708T1 (de) 1998-10-15
EP0598899B1 (en) 1998-09-30
EP0598899A1 (en) 1994-06-01
JPH06509821A (ja) 1994-11-02
ES2123059T3 (es) 1999-01-01
AU671660B2 (en) 1996-09-05
WO1993025571A1 (en) 1993-12-23
CA2115668A1 (en) 1993-12-23
AU4638193A (en) 1994-01-04
NZ254389A (en) 1996-03-26
IE921942A1 (en) 1993-12-29
DE69321324T2 (de) 1999-03-11
DE69321324D1 (de) 1998-11-05

Similar Documents

Publication Publication Date Title
DK0598899T3 (da) Væskefasesyntese af peptider og peptidderivater
SE9301911D0 (sv) New peptide derivatives
PT89961A (pt) Processo para a preparacao de n-carboxianidridos de aminoacidos protegidos por uretano
DK0623144T3 (da) Syntetiske peptider til detoksificering af bakterielle endotoksiner og behandling af septisk shock
DK0463450T3 (da) Vasoaktive intestinale polypeptid-analoger og udnyttelsen heraf
BR9408087A (pt) Recuperação de um aminoácido
DK0538754T3 (da) Anvendelse af antistofholdige præparater til immunundertrykkelse
PT83535B (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de aminoacidos
DK0437563T3 (da) Bioligiske aktive lægemiddelpolymerderivater
EP0123950A3 (en) Intermediates for thymosin alpha 1 and desacetylthymosin alpha 1
NO983691L (no) Forbindelser tilh°rende amidiniumfamilien, farmas°ytiske preparater inneholdende disse samt anvendelse derav
ES2137620T3 (es) Ligandos peptidicos para la region constante de las inmunoglobulinas.
DK0463053T3 (da) Fremstilling og anvendelse af anthelmintiske midler og beskyttende immunogener
DE69830866D1 (de) Verfahren zur Herstellung von Nitroguanidin-Derivaten ausgehend von 2-Nitroimino-hexahydro-1,3,5-triazinen in Anwesenheit von Ammoniak, primärem oder sekundärem Amin
DE69002881T2 (de) Peptide und deren Benutzung.
ATE45165T1 (de) Reduzierte peptide, hemmungsstoffe gastrischer ausscheidung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
IL105036A0 (en) Method and intermediates for peptide synthesis
CA1264899C (en) SYNTHESIS OF PEPTIDES USING THIOXANTHYLMETHYLOXYCARBONYL DIOXIDES
BR9815448A (pt) Derivados de imino-aza-antraciclinona para o tratamento de amiloidose
PT83837B (pt) Processo para a preparacao de peptideos por utilizacao de percloratos
ES2086947T3 (es) Metodo para encolar productos basados en madera.
DK0661328T3 (da) Hidtil ukendte epoxid-amin-addukter som hærdere til vandige epoxidsystemer
NO910664L (no) Fremgangsmaate ved fremstilling av lh-rh-analoger med temporaer og minimal beskyttelse.
AU1779088A (en) Guanidine-related compounds comprising a tetraphenylborate ion, process for obtaining these compounds and use of the compounds in peptide synthesis
ATE283276T1 (de) Deoxyhypusin reagenz und peptide